Green tech company OzoneBio (IndieBio SF11 2021) was recently spotlighted in Bioenterprise’s feature, “Start-up uses waste to create world’s first emissions-free bio-nylon”.

Bio Market Insights reports that the New York-based SOSV IndieBio startup Bucha Bio has raised $550,000 to accelerate production of its planet- and animal-friendly material Mirai.

Biotherapeutics company Prellis Biologics (IndieBio SF05 2017) has appointed Michael Nohaile, PhD as its new CEO, according to a Business Wire press release, “Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development”.  The company also announced a […]

“‘Why is there no great alternative to regular animal or plastic furs?’ is the million-dollar question that led biochemist Martin Stübler to launch biomaterials company Biofluff,” wrote WWD, in its article on the plant-based fur alternative’s recent $2.5M seed round. “It was important to us not to use plant material that’s in competition with a human […]

IndieBio’s regenerative agriculture specialist Puna Bio (IndieBio SF12 2021) has secured $3.7 million in a seed round led by Builders VC and At One Ventures, TechCrunch revealed in its article “Puna Bio’s extremophile microbe menagerie survives and revives depleted soil”. Other participants in the funding round include SOSV/IndieBio, SP Ventures, Air Capital, GLOCAL, and Grid […]

The New York Times recently spotlighted Geltor, an alt-protein company in Indie Bio’s portfolio (IBSF02 2015), in the article, “Is Bio-Designed Collagen the Next Step in Animal Protein Replacement?”. The New York Times charts Geltor’s foray into the production of bio-engineered collagen, produced without any animal ingredients, and the firm’s success in working with cosmetics […]

Two Cornell-based IndieBio startups Halomine (NY 01) and Inso Biosciences (NY 03) won support from the New York State Biodefense Commercialization Fund to develop solutions that will prevent future disease outbreaks like COVID-19, the Cornell Daily Sun reported in the article “NYS Funds Cornell Startups To Combat New Disease Outbreaks”. Halomine’s primary technology, HaloFilm, extends […]

TechCrunch “Stämm Biotech raises $17M for its next-generation, 3D printed bioreactor” reported the series A round was led by Verana Capital and supported by several new and follow-on investors, including SOSV.

Biomaterials company BioAesthetics (IndieBio 05) has been developing a nipple-areolar complex (NAC) graft for breast cancer survivors, and New Orleans 4WWL TV News tells the story of the first successful graft in, “Breast cancer survivor receives breakthrough nipple, areola reconstruction surgery”.  Breast cancer survivors who have undergone mastectomies usually cannot keep their nipples and areolas […]

The TechCrunch article  “The Every Co. grabs $175M as it cracks code on animal-free protein products” reports on a series C round raised by the IndieBio alum The Every Co. (fka Clara Foods), from IndieBio’s first cohort.